Second-Half Vascepa Sales Growth Still in Focus for Amarin (AMRN); Aegis Maintains at 'Hold'
Go back to Second-Half Vascepa Sales Growth Still in Focus for Amarin (AMRN); Aegis Maintains at 'Hold'| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 13.83 +0.35 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.48 | 52 Week High | $3.65 | |||
| Open | $13.52 | 52 Week Low | $1.24 | |||
| Day High | $13.90 | P/E | N/A | |||
| Day Low | $13.52 | EPS | $0.00 | |||
| Volume | 35,975 | |||||
